Eberconazole

CAS : 128326-82-9

Ref. 3D-DFA32682

Informations sur le produit

• Nom: Eberconazole
• Synonymes: 1-(2,4-Dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-1H-imidazole, 1H-Imidazole, 1-(2,4-dichloro-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)-

Description

Eberconazole is an analog of a protein kinase inhibitor that has been shown to have anticancer properties. It is used in the treatment of various types of cancer and tumors in humans. Eberconazole works by inhibiting cyclin-dependent kinases, which are enzymes involved in cell division and growth. This inhibition leads to apoptosis, or programmed cell death, in cancer cells. Eberconazole has been found to be effective against Chinese hamster ovary (CHO) cells and has shown promise as a potential anticancer drug. It is excreted primarily through urine after administration.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 329.2 g/mol
• Formule: C₁₈H₁₄Cl₂N₂
• Degré de pureté: Min. 95%